GILD · CUSIP 375558103
Gilead Sciences, Inc.
Reported by 3 of 79 curated managers in Q2 2026, in the holdings snapshot last exported 2026-08-24.
- Managers holding
- 3
- Average portfolio weight
- 0.6%
- Combined reported value
- $3.0B
- Research group
- 79
3 of the 79 superinvestors Shameless Cloning tracks reported Gilead Sciences, Inc. (GILD) in their Q2 2026 13F filings, worth $3.0B combined, at an average 0.6% of their portfolios. The largest positions by portfolio weight belong to Dodge & Cox Funds (1.6%), John Rogers (0.2%), Mairs & Power Funds (0.0%).
Reporting managers
This is a historical 13F snapshot, not a live shareholder register. The count covers all matched managers; dashboard rankings use only those with at least 95% coverage. Reported value is measured at filing quarter-end, not at today's price.
| Manager / SEC filer | % of portfolio | Reported value |
|---|---|---|
| Dodge & Cox FundsDodge & Cox | 1.6% | $3.0B |
| John RogersARIEL INVESTMENTS, LLC | 0.2% | $24.7M |
| Mairs & Power FundsMAIRS & POWER INC | 0.0% | $287K |